Adopting organoid technology for Co-infections: Innovative solutions for infectious diseases and cancer therapy
Microbial Pathogenesis · 2025
DOI: 10.1016/j.micpath.2025.107938 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbial Pathogenesis, 2025. Verfasst von Rana A Alaeq und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences, Faculty of Applied Medical Science, Taibah University, Al Madinah Al Munawarh, Saudi Arabia. Hauptthemen laut MEDLINE: Organoids, Neoplasms, Coinfection, Communicable Diseases. Die Arbeit nennt 254 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory Sciences, Faculty of Applied Medical Science, Taibah University, Al Madinah Al Munawarh, Saudi Arabia.
- Department of Clinical Laboratory Sciences, Faculty of Applied Medical Science, Taibah University, Al Madinah Al Munawarh, Saudi Arabia. Electronic address: Wmohammedsaeed@taibahu.edu.sa.
Zitieren
APA
Alaeq, R. A., & Mohammedsaeed, W. (2025). Adopting organoid technology for Co-infections: Innovative solutions for infectious diseases and cancer therapy. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2025.107938
Vancouver
Alaeq RA, Mohammedsaeed W. Adopting organoid technology for Co-infections: Innovative solutions for infectious diseases and cancer therapy. Microbial Pathogenesis. 2025. doi:10.1016/j.micpath.2025.107938
BibTeX
@article{Alaeq2025,
author = {Alaeq, Rana A and Mohammedsaeed, Walaa},
title = {Adopting organoid technology for Co-infections: Innovative solutions for infectious diseases and cancer therapy},
journal = {Microbial Pathogenesis},
year = {2025},
doi = {10.1016/j.micpath.2025.107938}
}
EUVIMED